INFORMATION REQUIRED IN REGISTRATION STATEMENT
Item 1 |
Description of Registrants Securities to be Registered. |
On August 23, 2023, the board of directors (the Board) of Baudax Bio, Inc. (the Company) declared a
dividend of one one-thousandth (1/1,000th) of a share of Series C Preferred Stock, par value $0.01 per share (Series C Preferred Stock), for each outstanding share of the
Companys common stock, par value $0.01 per share (Common Stock) to shareholders of record at 5:00 p.m. Eastern Time on September 5, 2023 (the Record Date).
General; Transferability. Shares of Series C Preferred Stock will be uncertificated and represented in book-entry form. No shares of Series C
Preferred Stock may be transferred by the holder thereof except in connection with a transfer by such holder of any shares of Common Stock held by such holder, in which case a number of one one-thousandths
(1/1,000ths) of a share of Series C Preferred Stock equal to the number of shares of Common Stock to be transferred by such holder will be automatically transferred to the transferee of such shares of Common Stock.
Voting Rights. Each share of Series C Preferred Stock will entitle the holder thereof to 1,000,000 votes per share (and, for the avoidance of
doubt, each fraction of a share of Series C Preferred Stock will have a ratable number of votes). Thus, each one-thousandth (1/1,000th) of a share of Series C Preferred Stock would entitle the holder thereof
to 1,000 votes. The outstanding shares of Series C Preferred Stock will vote together with the outstanding shares of Common Stock of the Company as a single class exclusively with respect to (1) any proposal to adopt an amendment to the
Companys Amended and Restated Articles of Incorporation, as amended (the Articles of Incorporation), to reclassify the outstanding shares of Common Stock into a smaller number of shares of Common Stock at a ratio
specified in or determined in accordance with the terms of such amendment (the Reverse Stock Split) and (2) any proposal to adjourn any meeting of shareholders called for the purpose of voting on the Reverse Stock
Split (the Adjournment Proposal). The Series C Preferred Stock will not be entitled to vote on any other matter, except to the extent required under the Pennsylvania Business Corporation Law.
Unless otherwise provided on any applicable proxy or ballot with respect to the voting on the Reverse Stock Split or the Adjournment Proposal, the vote of
each share of Series C Preferred Stock (or fraction thereof) entitled to vote on the Reverse Stock Split, the Adjournment Proposal or any other matter brought before any meeting of shareholders held to vote on the Reverse Stock Split and the
Adjournment Proposal will be cast in the same manner as the vote, if any, of the share of Common Stock (or fraction thereof) in respect of which such share of Series C Preferred Stock (or fraction thereof) was issued as a dividend is cast on the
Reverse Stock Split, the Adjournment Proposal or such other matter, as applicable, and the proxy or ballot with respect to shares of Common Stock held by any holder on whose behalf such proxy or ballot is submitted will be deemed to include all
shares of Series C Preferred Stock (or fraction thereof) held by such holder. Holders of Series C Preferred Stock will not receive a separate ballot or proxy to cast votes with respect to the Series C Preferred Stock on the Reverse Stock Split, the
Adjournment Proposal or any other matter brought before any meeting of shareholders held to vote on the Reverse Stock Split.
Dividend
Rights. The holders of Series C Preferred Stock, as such, will not be entitled to receive dividends of any kind.
Liquidation
Preference. The Series C Preferred Stock will rank senior to the Common Stock as to any distribution of assets upon a liquidation, dissolution or winding up of the Company, whether voluntarily or involuntarily (a
Dissolution). Upon any Dissolution, each holder of outstanding shares of Series C Preferred Stock will be entitled to be paid out of the assets of the Company available for distribution to shareholders, prior and in
preference to any distribution to the holders of Common Stock, an amount in cash equal to $0.01 per outstanding share of Series C Preferred Stock.
Redemption. All shares of Series C Preferred Stock that are not present in person or by proxy at any meeting of shareholders held to vote on the
Reverse Stock Split and the Adjournment Proposal as of immediately prior to the opening of the polls at such meeting (the Initial Redemption Time) will automatically be redeemed in whole, but not in part, by the Company at
the Initial Redemption Time without further action on the part of the Company or the holder of shares of Series C Preferred Stock (the Initial Redemption). Any outstanding shares of Series C Preferred Stock that have not
been redeemed pursuant to an Initial Redemption will be redeemed in whole, but not in part, (i) if such redemption is ordered by the Board in its sole discretion, automatically and effective on such time and date specified by the Board in its
sole discretion or (ii) automatically upon the approval by the Companys shareholders of the Reverse Stock Split at any meeting of the shareholders held for the purpose of voting on such proposal.